{
  "paper_metadata": {
    "pmid": "23884293",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted variants in the BRCA2 gene along with penetrance data from the study."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": null,
      "protein_notation": "p.N289H",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 1,
        "demographics": "HER2-positive patient",
        "phenotype": "breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "breast cancer",
          "evidence_sentence": "The two BRCA2 missense substitutions were seen in HER2-positive patients."
        }
      ],
      "functional_data": {
        "summary": "The variant is associated with breast cancer predisposition.",
        "assays": []
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The variant was previously associated with breast cancer through family or case-control studies.",
      "key_quotes": [
        "The two BRCA2 missense substitutions were seen in HER2-positive patients."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": null,
      "protein_notation": "p.D1420Y",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 1,
        "demographics": "HER2-positive patient",
        "phenotype": "breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "breast cancer",
          "evidence_sentence": "The two BRCA2 missense substitutions were seen in HER2-positive patients."
        }
      ],
      "functional_data": {
        "summary": "The variant is associated with breast cancer predisposition.",
        "assays": []
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The variant was previously associated with breast cancer through family or case-control studies.",
      "key_quotes": [
        "The two BRCA2 missense substitutions were seen in HER2-positive patients."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 2,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data regarding BRCA2 variants and penetrance were extracted."
  }
}